EP1077704A4 - Kombinationstherapie zur behandlung der depression - Google Patents
Kombinationstherapie zur behandlung der depressionInfo
- Publication number
- EP1077704A4 EP1077704A4 EP99921795A EP99921795A EP1077704A4 EP 1077704 A4 EP1077704 A4 EP 1077704A4 EP 99921795 A EP99921795 A EP 99921795A EP 99921795 A EP99921795 A EP 99921795A EP 1077704 A4 EP1077704 A4 EP 1077704A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- depression
- treatment
- combination therapy
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8626898P | 1998-05-21 | 1998-05-21 | |
US86268P | 1998-05-21 | ||
PCT/US1999/010092 WO1999059593A1 (en) | 1998-05-21 | 1999-05-10 | Combination therapy for treatment of depression |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1077704A1 EP1077704A1 (de) | 2001-02-28 |
EP1077704A4 true EP1077704A4 (de) | 2002-01-30 |
Family
ID=22197424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99921795A Withdrawn EP1077704A4 (de) | 1998-05-21 | 1999-05-10 | Kombinationstherapie zur behandlung der depression |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1077704A4 (de) |
JP (1) | JP2002515435A (de) |
AU (1) | AU3891299A (de) |
CA (1) | CA2332253A1 (de) |
WO (1) | WO1999059593A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US6174882B1 (en) * | 1998-11-23 | 2001-01-16 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
GB2362826A (en) * | 2000-06-02 | 2001-12-05 | Lilly Co Eli | A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist |
US20020107244A1 (en) * | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
US6635675B2 (en) * | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
US7005138B2 (en) * | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
JPWO2004014429A1 (ja) * | 2002-08-09 | 2005-12-02 | 三菱ウェルファーマ株式会社 | 精神疾患発症脆弱性制御剤 |
US7704527B2 (en) | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
US20040121010A1 (en) * | 2002-10-25 | 2004-06-24 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
JP2006506461A (ja) * | 2002-10-25 | 2006-02-23 | コルジウム ファーマシューティカル, インコーポレイテッド | ミルナシプランのパルス型放出組成物 |
PT1575590E (pt) | 2002-12-27 | 2007-12-06 | Otsuka Pharma Co Ltd | Derivados de carboestirilo e inibidores da reabsorção de serotonina para o tratamento de distúrbios de humor |
AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
US20040228830A1 (en) * | 2003-01-28 | 2004-11-18 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
EP1795196A3 (de) * | 2003-04-04 | 2008-02-06 | Dynogen Pharmaceuticals, Inc. | Verfahren zur Behandlung von Erkrankungen der unteren Harnwege |
AU2004227945B2 (en) * | 2003-04-04 | 2006-10-26 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
EP1713486A4 (de) | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | Kombinationstherapie für demenz, depression und apathie |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
WO2008000760A1 (en) | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
AR062321A1 (es) | 2006-08-25 | 2008-10-29 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992000103A1 (en) * | 1990-06-28 | 1992-01-09 | Beecham Group Plc | Pharmaceutical preparations |
EP1094818A1 (de) * | 1998-05-19 | 2001-05-02 | Dalhousie University | Verwendung tricyclischer antidepressiva zur lokalen analgesie |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4973594A (en) * | 1986-12-17 | 1990-11-27 | Glaxo Group Limited | Medicaments |
-
1999
- 1999-05-10 AU AU38912/99A patent/AU3891299A/en not_active Abandoned
- 1999-05-10 JP JP2000549258A patent/JP2002515435A/ja not_active Withdrawn
- 1999-05-10 CA CA002332253A patent/CA2332253A1/en not_active Abandoned
- 1999-05-10 WO PCT/US1999/010092 patent/WO1999059593A1/en not_active Application Discontinuation
- 1999-05-10 EP EP99921795A patent/EP1077704A4/de not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992000103A1 (en) * | 1990-06-28 | 1992-01-09 | Beecham Group Plc | Pharmaceutical preparations |
EP1094818A1 (de) * | 1998-05-19 | 2001-05-02 | Dalhousie University | Verwendung tricyclischer antidepressiva zur lokalen analgesie |
Non-Patent Citations (3)
Title |
---|
D'SOUZA, D.L. ET AL.: "Effect of alosetron on the pharmacokinetics of fluoxetine", J CLIN PHARMACOL, vol. 41, 2001, pages 455 - 458, XP001034110 * |
KORIECH, O.M.: "Fluoxetine treatment comprises the antiemetic efficacy of ondasetron in cancer patients", CLINICAL ONCOLOGY, vol. 7, 1995, pages 371 - 372, XP001034101 * |
See also references of WO9959593A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1077704A1 (de) | 2001-02-28 |
AU3891299A (en) | 1999-12-06 |
WO1999059593A1 (en) | 1999-11-25 |
JP2002515435A (ja) | 2002-05-28 |
CA2332253A1 (en) | 1999-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1077704A4 (de) | Kombinationstherapie zur behandlung der depression | |
GB9824436D0 (en) | Methods of treatment | |
EP1063990A4 (de) | Therapie von estrogenabhängigen erkrankungen | |
PL344304A1 (en) | Combination therapy for treatment of bipolar disorders | |
PL344331A1 (en) | Combination therapy for treatment of refractory depression | |
IL142588A0 (en) | Therapy for improving cognition | |
HU0002509D0 (en) | Combination therapy for treatment of migraine | |
GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
IL135994A0 (en) | Combination therapy for the treatment of aids | |
HU0002508D0 (en) | Combination therapy for treatment of migraine | |
EP0981545A4 (de) | Behandlung von osteoporose | |
IL136025A0 (en) | Combination therapy for the treatment of migraine | |
GB9819999D0 (en) | Treatment of cancer | |
GB0020261D0 (en) | Therapeutic treatment | |
IL136024A0 (en) | Combination therapy for the treatment of migraine | |
GB2343629B (en) | Treatment of cellulite | |
GB9704174D0 (en) | Agent for medical treatment | |
IL120955A0 (en) | Treatment of osteoporosis | |
PL346528A1 (en) | Treatment of depression | |
ZA9810306B (en) | Combination therapy for the treatment of aids | |
GB9721978D0 (en) | Treatment of depression | |
GB9819590D0 (en) | Combination therapy for the treatment of aids | |
GB9807938D0 (en) | Combination therapy for the treatment of AIDS | |
SI1068199T1 (en) | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001120 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20001120;LT PAYMENT 20001120;LV PAYMENT 20001120;RO PAYMENT 20001120;SI PAYMENT 20001120 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011218 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/55 A, 7A 61K 31/44 B, 7A 61K 31/415 B, 7A 61K 31/445 B, 7A 61K 31/34 B, 7A 61K 31/15 B, 7A 61K 31/135 B, 7A 61K 31/38 B, 7A 61K 31/55 J, 7A 61K 31:135 J, 7A 61K 31:38 J, 7A 61K 31:445 J |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020302 |
|
R18D | Application deemed to be withdrawn (corrected) |
Effective date: 20020301 |